Log In
Print this Print this

OPT-302 (formerly VGX-300)

  Manage Alerts
Collapse Summary General Information
Company Opthea Ltd.
DescriptionSoluble form of human VEGF receptor 3 (FLT4; VEGFR-3)
Molecular Target Vascular endothelial growth factor C (VEGF-C) ; Vascular endothelial growth factor D (VEGF-D)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today